More recently, we have reported that the inhibition of LPLA2 activity is highly predictive of drug-induced phospholipidosis by scores of agents associated with lysosomal phospholipid accumulation in either in vitro or in vivo studies (12). The gene discussed is PLA2G15; the disease is lysosomal storage disease.